drug · small molecule
patient view →rifamycin
Phase 2updated 2mo agoby Cosmo Pharmaceuticals NV🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 2 investigational indications.
indications
indications
IBD (Crohn's + UC)
targets
DNA-directed RNA polymerase
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that